BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC
December 05, 2022 12:52 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today announced that Mr. Nis Kruse joined the Company as EVP of Strategic...
BioPorto Announces Interim Results for the First Nine Months of 2022
November 09, 2022 02:05 ET
|
BioPorto A/S
Announcement no. 15 COPENHAGEN, Denmark and BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first nine months of...
BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call
November 03, 2022 12:05 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury,...
BioPorto to Participate in H.C. Wainwright’s 24th Annual Global Investment Conference
September 08, 2022 08:00 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced plans to participate in the H.C. Wainwright 24th Annual Global Investment...
BioPorto Announces Interim Results for the First Six Months of 2022
August 17, 2022 02:20 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first six months of 2022 and business...
BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call
August 08, 2022 11:05 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury,...
BioPorto Achieves Targeted Enrollment in Clinical Study Supporting FDA De Novo Submission for The NGAL Test in the U.S.
June 28, 2022 15:02 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced its achievement of targeted subject enrollment for the third part of a 3-part...
Moderated Webcast with BioPorto’s Management
June 21, 2022 11:00 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (CPH:BIOPOR) (BioPorto) today provided details of a previously announced session with members of its management team. ...
BioPorto Appoints World Leading Expert and Pioneer on the Clinical Utility of the NGAL Biomarker, Dr. Prasad Devarajan, MD FAAP FASN, as New Senior Medical Director
June 20, 2022 02:15 ET
|
BioPorto A/S
COPENHAGEN, Denmark and BOSTON, June 20, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (CPH:BIOPOR) (BioPorto) today announced the appointment of Dr. Prasad Devarajan, MD FAAP FASN, as Senior Medical...
BioPorto Appoints New President of BioPorto Diagnostics, Inc.
April 15, 2019 09:00 ET
|
BioPorto A/S
Company Plans to Bring Novel Kidney Diagnostic to US Market Hellerup, Denmark, April 15, 2019 (GLOBE NEWSWIRE) -- Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the appointment of Amy...